In fact, there is a clear trend towards an increase in these cells [ 26 - 29 ], a finding that is not that surprising taking into account that these antibodies are blocking but not depleting antibodies for CTLA4 positive cells.
← all excerpts
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
1
—
—